Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
Qiming Zhou, Yao Peng, Fenfen Ji, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

The significant role of amino acid metabolic reprogramming in cancer
Xiaohong Liu, Bo Ren, Jie Ren, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 16
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
Qinglong Ma, Wenyang Zhang, Kongming Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review)
Wenjuan Zeng, Haohan Liu, Yuanhao Mao, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Closed Access | Times Cited: 10
Comprehensive review of amino acid transporters as therapeutic targets
Ran Xia, Hai-Feng Peng, Xing Zhang, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129646-129646
Closed Access | Times Cited: 7
NIR Emissive Functional Nanoparticles Promote Precise Pancreatic Cancer Therapy by Co‐Targeting Mutant p53 and Oncogenic KRAS
Jieying Qian, Zhenyu Yang, Wang Zhang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 18
Closed Access | Times Cited: 6
Immunomodulatory Molecules in Colorectal Cancer Liver Metastasis
W. Kong, Jia-Jun Li, Yuqing Deng, et al.
Cancer Letters (2024) Vol. 598, pp. 217113-217113
Closed Access | Times Cited: 4
Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma
Yan Liao, Junkai Chen, Hao Yao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Comprehensive analysis of mitochondrial solute carrier family 25 (SLC25) identifies member 19 (SLC25A19) as a regulatory factor in hepatocellular carcinoma
Xueke Gao, Yangtao Xu, Xinyao Hu, et al.
Gene (2025), pp. 149299-149299
Closed Access
Sirtuin 3 Protects Lung Adenocarcinoma from Ferroptosis by Deacetylating and Stabilizing Mitochondrial Glutamate Transporter Solute Carrier Family 25 Member A22
Xiangyun Wei, Tiange Wang, Zhengcao Xing, et al.
Antioxidants (2025) Vol. 14, Iss. 4, pp. 403-403
Open Access
Asparagine: A key metabolic junction in targeted tumor therapy
Xuan Wang, Weijian Gong, Xueyou Xiong, et al.
Pharmacological Research (2024) Vol. 206, pp. 107292-107292
Open Access | Times Cited: 4
Mechanisms of myeloid-derived suppressor cell-mediated immunosuppression in colorectal cancer and related therapies
Shu-Chang Nie, Yanhua Jing, Lu Lu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 5, pp. 1690-1704
Open Access | Times Cited: 2
Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review
Renzhuo Gao, Dan Zhou, Xingpeng Qiu, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
Neutrophil and Colorectal Cancer
Hideyuki Masui, Kenji Kawada, Kazutaka Obama
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 6-6
Open Access | Times Cited: 2
Novel GSH-responsive prodrugs derived from indole-chalcone and camptothecin trigger apoptosis and autophagy in colon cancer
Hui Wang, Caiyun Nie, Miao Liang Luo, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107056-107056
Closed Access | Times Cited: 4
Combination of miR159 Mimics and Irinotecan Utilizing Lipid Nanoparticles for Enhanced Treatment of Colorectal Cancer
Rulei Yang, Yiran Liu, Ning Yang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 570-570
Open Access | Times Cited: 1
Role played by MDSC in colitis-associated colorectal cancer and potential therapeutic strategies
Kang Wang, Yun Wang, Kai Yin
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 1
The aminophospholipid transporter, ATP8B3, as a potential biomarker and target for enhancing the therapeutic effect of PD-L1 blockade in colon adenocarcinoma
Weihao Zhang, Yongjie Xie, Ziyun Liu, et al.
Genomics (2024) Vol. 116, Iss. 5, pp. 110907-110907
Open Access | Times Cited: 1
Challenges in validation of combination treatment strategies for CRC using patient-derived organoids
Valentin Benboubker, George M. Ramzy, S. Jacobs, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
SLC25 family with energy metabolism and immunity in malignant tumors
Guiqian Zhang, Ning Wang, Shi‐Xun Ma, et al.
ONCOLOGIE (2023) Vol. 26, Iss. 1, pp. 65-77
Open Access | Times Cited: 2
Metabolic reprogramming in KRAS-mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies
Ruilin Wu, Hong Zhu, Qiaojun He, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 12, pp. 104220-104220
Closed Access
Targeting tumor metabolism to augment CD8+ T cell anti-tumor immunity
Huan Liu, Yang Wenyong, Jingwen Jiang
Journal of Pharmaceutical Analysis (2024), pp. 101150-101150
Open Access
SQLE-mediated squalene metabolism promotes tumor immune evasion in pancreatic cancer
Junchen Pan, Haixi Liang, Lin Zhou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
The Role of Mitochondrial Solute Carriers SLC25 in Cancer Metabolic Reprogramming: Current Insights and Future Perspectives
Amer Ahmed, Giorgia Natalia Iaconisi, Daria Di Molfetta, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 92-92
Open Access
Page 1

Scroll to top